Ingredient intelligence

Ectoin

Skin barrier · Ectoin · C6H10N2O2

Ectoin is a bacterial compatible solute studied as a protein- and membrane-stabilising osmolyte in skin models.

Molecular identity

Two-dimensional chemical structure of Ectoin
Formula
C6H10N2O2
Molecular weight
142.16 g/mol
PubChem CID
126041
ChEBI
Data unavailable
Open PubChem record →

Biological targets

  • Membrane and protein hydration shell

    medium confidence

    associated with · complex

    Physicochemical stabilisation rather than a protein target.

Molecules & genes

Molecules

  • EctoinC6H10N2O2 · 142.16 g/mol

Genes / proteins

How could this ingredient interact with biology?

Biological network

Ingredient → molecule → target → gene/protein → pathway → process → studied outcome. Relationship strength is drawn from the curated confidence tier; nothing is added to make the chain look complete.

100%
EctoinEctoinMembrane and protein hydr…

drag to pan · hover to isolate a path · click a node for detail

IngredientMoleculeTargetGenePathwayProcessOutcome

5 lower-confidence relationships are hidden at this filter level. Use “Show more biology” to include them.

Text alternative for this network
  • Ectoin is molecule Ectoinhigh confidence
  • Ectoin associated with Membrane and protein hydration shellmedium confidence

Biological pathways

Cellular response to heat stress

low confidence

Stress-protein responses reported in exposed keratinocytes.

Reactome R-HSA-3371556

Evidence engine

Insufficient

Not enough curated evidence to characterise this ingredient.

Skinceptor Evidence Index

12

experimental · of 100

This index is a research-navigation aid describing how much evidence exists and how it was produced. It is not a medical safety score, an efficacy guarantee, or a clinical recommendation.

Study composition

  • In-vitro1
Total studies
1
Human studies
0
Largest sample
Data unavailable
Range
2007–2007

Index breakdown

  • Study design quality25% × 28%

    Mean design weight across curated studies (meta-analysis 1.0, RCT 0.9, other human 0.7, review 0.45, animal 0.35, in-vitro 0.25).

  • Human evidence share0% × 22%

    Proportion of curated evidence measured in people rather than cells or animals.

  • Evidence volume32% × 14%

    Log-scaled count of curated studies, so volume alone cannot dominate the score.

  • Largest sample size0% × 12%

    Log-scaled largest reported sample size across curated human studies.

  • Replication0% × 12%

    Independent human studies, capped at three; one study is never treated as replicated.

  • Recency5% × 7%

    Linear decay over a twenty-year window from the most recent curated publication.

  • Source traceability0% × 5%

    Share of curated studies with a verified PMID or DOI in this dataset.

How is this determined? →

Insufficient comparable evidence for quantitative synthesis.

Research timeline

How the evidence accumulated

  1. 2007

    Ectoin as a protective compatible solute in keratinocyte models

    In-vitrosample size unavailable · Skin Pharmacology and Physiology

Ingredient fingerprint

8 nodes · 8 relationships · seed "ectoin"

The fingerprint is a deterministic visual signature: ridge amplitude comes from the number of entities in each tier, node placement from identifier hashes, and opacity from confidence. Two ingredients can never produce the same figure unless their networks are identical.

Open in Biology as Art →

Research

1 curated study

In-vitroSkin Pharmacology and Physiology · 2007

Ectoin as a protective compatible solute in keratinocyte models

Reported reduced UVA-induced signalling and membrane damage in ectoin-treated keratinocytes.

LimitationsCell model; identifier not verified during curation.

Community evidence

Submitted by readers

Submit a study

Reader submissions appear here only after review. They are not part of the curated dataset and do not affect the Skinceptor Evidence Index.

No approved community submissions yet.

Sources